SUNYANI, GHANA -- (Marketwire) -- 11/15/12 -- Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma Inc. strategic partner African Global Pharma Corp. (AGP) is negotiating an agreement to distribute our full line of pharmaceutical products to several West African countries. Ghana acts as the gateway to a huge sub-regional market of over 250 million people. This is the first endeavour for AGP to broaden our market base outside of Ghana. The current line of medicines being produced in AGP's Ghana manufacturing facility are Glaten® (anti-hypertensive), Glibenclamide (anti-diabetic), Globartem®, Gloderp (anti-malarials) and Paracetamol (pain relieving analgesic). "We are proud to announce this collaboration. Together with African Global Pharma GH, our company will continue to expand the distribution of our product line in the West African market. We see great commercial potential in the product line going forward. We endeavor to ensure the availability of world class, quality medicines within reach at affordable prices," stated Emerging World Pharma President Steve Ignatavicius.
About African Global Pharma, Ghana
African Global Pharma (Ghana) Limited is an affiliated company of African GlobalPharma Corp. of Canada with business partnership with the Catholic Diocese of Sunyani to distribute all our manufactured drugs to the Catholic Mission Hospitals. African Global Pharma's production facility in Sunyani, Ghana was fully rehabilitated and built by African Global Pharma Corp., Canada. The plant and its operations are headquartered in Sunyani at the Diocesan Bldg.
For more on AGP click here http://www.globalpharmacorp.ca/african-gp-ghana.html
About Emerging World Pharma Inc.
Emerging World Pharma Inc. is an investor in generic based pharmaceutical companies manufacturing within developing nations. The company focuses its investments on generic pharmaceutical companies that have contracts with three major buyer groups; church, government and wholesalers. Market research shows that these branches are the most secure, protected and reputable for the distribution of medicines.
For more on Emerging World Pharma Inc. click here http://www.emergingpharma.com/
Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.
Emerging World Pharma Inc.
Investor Relations Division
Most Popular Stories
- Americans Still Pessimistic Despite Economic Growth
- GE Capital and Petters-Related Fund in Legal Battle
- Combating Online Abuse Not Easy for Gamers
- Feds Want Nuclear Waste Train, but Nowhere to Go
- California Conservation Conundrum: Water Use Varies Greatly Across State
- Even With Surly 2014 Electorate, It's 'Still an Incumbent's World'
- Detroit Raced Toward this Week's Bankruptcy Trial
- New Hershey's Logo Revealed
- California Passes First US Statewide Bag Ban
- Obama on Labor Day: Don't Take Rights for Granted